Drappa Jorn — SEC insider filings

SEC reporting owner CIK 1789317. 13 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2021-03-15 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ALUMIS INC. (ALMS)Chief Medical Officer7—2 legs · 3,040 sh · $68,39425
ALPINE IMMUNE SCIENCES, INC. (ALPN)Director4——6
Viela Bio, Inc. (VIE)Chief Medical Officer1——4
Ventyx Biosciences, Inc. (VTYX)Chief Medical Officer1——1

Insider filings — Drappa Jorn

FiledFormIssuerReported transactionsSource
2026-11-044ALUMIS INC. (ALMS)Sale (S): 593 @ $6.52EDGAR
2026-08-054ALUMIS INC. (ALMS)Sale (S): 2,447 @ $26.37EDGAR
2026-05-274ALUMIS INC. (ALMS)Option exercise (M): 11,317 @ $8.84 · Option exercise (M): 15,535 @ $5.06 · Option exercise (M): 11,317 (derivative) @ $0 · Option exercise (M): 15,535 (derivative) @ $0EDGAR
2026-01-284ALUMIS INC. (ALMS)Grant/award (A): 221,450 (derivative) @ $0EDGAR
2025-07-314ALUMIS INC. (ALMS)Grant/award (A): 25,450 @ $0 · Grant/award (A): 101,850 (derivative) @ $0EDGAR
2025-02-204ALUMIS INC. (ALMS)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2024-07-014ALUMIS INC. (ALMS)Grant/award (A): 5,347 (derivative) @ $0 · Disposition to issuer (D): 5,347 (derivative) @ $0 · Grant/award (A): 5,347 (derivative) @ $0 · Disposition to issuer (D): 85,561 (derivative) @ $0 · Grant/award (A): 85,561 (derivative) @ $0 · Disposition to issuer (D): 171,122 (derivative) @ $0 · +11 moreEDGAR
2024-05-204ALPINE IMMUNE SCIENCES, INC. (ALPN)Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 17,500 (derivative)EDGAR
2024-01-044ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-01-054ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-07-194ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-02-044Ventyx Biosciences, Inc. (VTYX)Grant/award (A): 145,000 (derivative) @ $0EDGAR
2021-03-154Viela Bio, Inc. (VIE)Disposition to issuer (D): 202,661 @ $53 · Disposition to issuer (D): 71,842 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 165,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789317 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs